Report Detail

Pharma & Healthcare Global Buspirone Market Research Report 2021

  • RnM4300905
  • |
  • 05 April, 2021
  • |
  • Global
  • |
  • 124 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Buspirone Market Overview

  • 1.1 Product Overview and Scope of Buspirone
  • 1.2 Buspirone Segment by Type
    • 1.2.1 Global Buspirone Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 5mg
    • 1.2.3 10mg
    • 1.2.4 15mg
    • 1.2.5 30mg
  • 1.3 Buspirone Segment by Application
    • 1.3.1 Buspirone Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Drug Store
  • 1.4 Global Buspirone Market Size Estimates and Forecasts
    • 1.4.1 Global Buspirone Revenue 2016-2027
    • 1.4.2 Global Buspirone Sales 2016-2027
    • 1.4.3 Buspirone Market Size by Region: 2016 Versus 2021 Versus 2027

2 Buspirone Market Competition by Manufacturers

  • 2.1 Global Buspirone Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Buspirone Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Buspirone Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Buspirone Manufacturing Sites, Area Served, Product Type
  • 2.5 Buspirone Market Competitive Situation and Trends
    • 2.5.1 Buspirone Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Buspirone Players Market Share by Revenue
    • 2.5.3 Global Buspirone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Buspirone Retrospective Market Scenario by Region

  • 3.1 Global Buspirone Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Buspirone Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Buspirone Market Facts & Figures by Country
    • 3.3.1 North America Buspirone Sales by Country
    • 3.3.2 North America Buspirone Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Buspirone Market Facts & Figures by Country
    • 3.4.1 Europe Buspirone Sales by Country
    • 3.4.2 Europe Buspirone Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Buspirone Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Buspirone Sales by Region
    • 3.5.2 Asia Pacific Buspirone Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Buspirone Market Facts & Figures by Country
    • 3.6.1 Latin America Buspirone Sales by Country
    • 3.6.2 Latin America Buspirone Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Buspirone Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Buspirone Sales by Country
    • 3.7.2 Middle East and Africa Buspirone Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Buspirone Historic Market Analysis by Type

  • 4.1 Global Buspirone Sales Market Share by Type (2016-2021)
  • 4.2 Global Buspirone Revenue Market Share by Type (2016-2021)
  • 4.3 Global Buspirone Price by Type (2016-2021)

5 Global Buspirone Historic Market Analysis by Application

  • 5.1 Global Buspirone Sales Market Share by Application (2016-2021)
  • 5.2 Global Buspirone Revenue Market Share by Application (2016-2021)
  • 5.3 Global Buspirone Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Bristol Myers Squibb
    • 6.1.1 Bristol Myers Squibb Corporation Information
    • 6.1.2 Bristol Myers Squibb Description and Business Overview
    • 6.1.3 Bristol Myers Squibb Buspirone Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Bristol Myers Squibb Product Portfolio
    • 6.1.5 Bristol Myers Squibb Recent Developments/Updates
  • 6.2 Apotex
    • 6.2.1 Apotex Corporation Information
    • 6.2.2 Apotex Description and Business Overview
    • 6.2.3 Apotex Buspirone Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Apotex Product Portfolio
    • 6.2.5 Apotex Recent Developments/Updates
  • 6.3 Dr. Reddy's Laboratories
    • 6.3.1 Dr. Reddy's Laboratories Corporation Information
    • 6.3.2 Dr. Reddy's Laboratories Description and Business Overview
    • 6.3.3 Dr. Reddy's Laboratories Buspirone Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Dr. Reddy's Laboratories Product Portfolio
    • 6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
  • 6.4 Laboratoires Servier
    • 6.4.1 Laboratoires Servier Corporation Information
    • 6.4.2 Laboratoires Servier Description and Business Overview
    • 6.4.3 Laboratoires Servier Buspirone Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Laboratoires Servier Product Portfolio
    • 6.4.5 Laboratoires Servier Recent Developments/Updates
  • 6.5 Teva
    • 6.5.1 Teva Corporation Information
    • 6.5.2 Teva Description and Business Overview
    • 6.5.3 Teva Buspirone Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Teva Product Portfolio
    • 6.5.5 Teva Recent Developments/Updates
  • 6.6 AMAG Pharmaceuticals
    • 6.6.1 AMAG Pharmaceuticals Corporation Information
    • 6.6.2 AMAG Pharmaceuticals Description and Business Overview
    • 6.6.3 AMAG Pharmaceuticals Buspirone Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 AMAG Pharmaceuticals Product Portfolio
    • 6.6.5 AMAG Pharmaceuticals Recent Developments/Updates
  • 6.7 Mylan
    • 6.6.1 Mylan Corporation Information
    • 6.6.2 Mylan Description and Business Overview
    • 6.6.3 Mylan Buspirone Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Mylan Product Portfolio
    • 6.7.5 Mylan Recent Developments/Updates
  • 6.8 Novartis
    • 6.8.1 Novartis Corporation Information
    • 6.8.2 Novartis Description and Business Overview
    • 6.8.3 Novartis Buspirone Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Novartis Product Portfolio
    • 6.8.5 Novartis Recent Developments/Updates
  • 6.9 Watson Laboratories
    • 6.9.1 Watson Laboratories Corporation Information
    • 6.9.2 Watson Laboratories Description and Business Overview
    • 6.9.3 Watson Laboratories Buspirone Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Watson Laboratories Product Portfolio
    • 6.9.5 Watson Laboratories Recent Developments/Updates
  • 6.10 Hikma
    • 6.10.1 Hikma Corporation Information
    • 6.10.2 Hikma Description and Business Overview
    • 6.10.3 Hikma Buspirone Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Hikma Product Portfolio
    • 6.10.5 Hikma Recent Developments/Updates
  • 6.11 Wockhardt
    • 6.11.1 Wockhardt Corporation Information
    • 6.11.2 Wockhardt Buspirone Description and Business Overview
    • 6.11.3 Wockhardt Buspirone Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Wockhardt Product Portfolio
    • 6.11.5 Wockhardt Recent Developments/Updates
  • 6.12 Cadila Healthcare
    • 6.12.1 Cadila Healthcare Corporation Information
    • 6.12.2 Cadila Healthcare Buspirone Description and Business Overview
    • 6.12.3 Cadila Healthcare Buspirone Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Cadila Healthcare Product Portfolio
    • 6.12.5 Cadila Healthcare Recent Developments/Updates
  • 6.13 Orion Corporation
    • 6.13.1 Orion Corporation Corporation Information
    • 6.13.2 Orion Corporation Buspirone Description and Business Overview
    • 6.13.3 Orion Corporation Buspirone Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Orion Corporation Product Portfolio
    • 6.13.5 Orion Corporation Recent Developments/Updates

7 Buspirone Manufacturing Cost Analysis

  • 7.1 Buspirone Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Buspirone
  • 7.4 Buspirone Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Buspirone Distributors List
  • 8.3 Buspirone Customers

9 Buspirone Market Dynamics

  • 9.1 Buspirone Industry Trends
  • 9.2 Buspirone Growth Drivers
  • 9.3 Buspirone Market Challenges
  • 9.4 Buspirone Market Restraints

10 Global Market Forecast

  • 10.1 Buspirone Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Buspirone by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Buspirone by Type (2022-2027)
  • 10.2 Buspirone Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Buspirone by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Buspirone by Application (2022-2027)
  • 10.3 Buspirone Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Buspirone by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Buspirone by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    5mg
    10mg
    15mg
    30mg

    Segment by Application
    Hospital
    Drug Store

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Bristol Myers Squibb
    Apotex
    Dr. Reddy's Laboratories
    Laboratoires Servier
    Teva
    AMAG Pharmaceuticals
    Mylan
    Novartis
    Watson Laboratories
    Hikma
    Wockhardt
    Cadila Healthcare
    Orion Corporation


    Summary:
    Get latest Market Research Reports on Buspirone. Industry analysis & Market Report on Buspirone is a syndicated market report, published as Global Buspirone Market Research Report 2021. It is complete Research Study and Industry Analysis of Buspirone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,097.28
    3,145.92
    4,194.56
    2,419.04
    3,628.56
    4,838.08
    315,609.90
    473,414.85
    631,219.80
    216,474.56
    324,711.84
    432,949.12
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report